Cellectar Biosciences, Inc. Proceeds from Long-Term Debt Issued
Cellectar Biosciences, Inc. (CLRB) reported Proceeds from Long-Term Debt Issued of $184.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2022-03-21
- Cellectar Biosciences, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- Cellectar Biosciences, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
- Cellectar Biosciences, Inc. proceeds from issuance of long-term debt for the quarter ending 2014-03-31 was $0.00.
- Cellectar Biosciences, Inc. proceeds from issuance of long-term debt for the quarter ending 2013-12-31 was $0.00.
- Cellectar Biosciences, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $184.00K.
- Cellectar Biosciences, Inc. proceeds from issuance of long-term debt for fiscal 2013 was $0.00.
- Cellectar Biosciences, Inc. proceeds from issuance of long-term debt for fiscal 2012 was $0.00.
- Cellectar Biosciences, Inc. proceeds from issuance of long-term debt for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 104 month | Proceeds from Issuance of Long-term Debt 107 month | Proceeds from Issuance of Long-term Debt 110 month | Proceeds from Issuance of Long-term Debt 113 month | Proceeds from Issuance of Long-term Debt 116 month | Proceeds from Issuance of Long-term Debt 119 month | Proceeds from Issuance of Long-term Debt 122 month | Proceeds from Issuance of Long-term Debt 125 month | Proceeds from Issuance of Long-term Debt 128 month | Proceeds from Issuance of Long-term Debt 131 month | Proceeds from Issuance of Long-term Debt 134 month | Proceeds from Issuance of Long-term Debt 137 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $184.00K 10-K · filed 2022-03-21 | |||||||||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $184.00K 10-Q · filed 2021-11-08 | ||||||||||||||
| 2020-06-30 | $184.00K 10-Q · filed 2021-08-09 | |||||||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $1.68M 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 derived: sum of 2 quarters · filed 2014-03-19 | $0.00 derived: sum of 3 quarters · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 | $1.68M 10-K · filed 2014-03-19 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $1.68M 10-Q · filed 2013-11-13 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $1.68M 10-Q · filed 2013-08-12 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $1.68M 10-Q · filed 2013-05-15 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 derived: sum of 2 quarters · filed 2014-03-19 | $0.00 derived: sum of 3 quarters · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 | $1.68M 10-K · filed 2013-03-28 | |||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-11-13 | $1.68M 10-Q · filed 2012-11-06 | |||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 | $0.00 derived: sum of 3 quarters · filed 2013-08-12 | $0.00 derived: sum of 4 quarters · filed 2013-08-12 | $1.68M 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | $0.00 derived: sum of 2 quarters · filed 2013-05-15 | $0.00 derived: sum of 3 quarters · filed 2013-05-15 | $1.68M 10-Q · filed 2012-05-04 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $0.00 derived: sum of 2 quarters · filed 2013-03-28 | $0.00 10-K · filed 2013-03-28 | $1.68M 10-K · filed 2012-03-09 | ||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $0.00 10-Q · filed 2012-11-06 | $1.68M 10-Q · filed 2011-11-07 | |||||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-09 | $1.68M 10-Q · filed 2011-08-12 | ||||||||||||||
| 2010-12-31 | $450.00K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |